Search results for " Endocrinology"

showing 10 items of 1321 documents

Reference Values of Thyroid Hormones During the First Trimester of Pregnancy in Valencian Community (Spain) and Their Relationship with Iodine Intake

2020

Thyroid hormones require special monitoring during the first trimester of gestation. Local reference values should be applied if available, especially in iodine-deficient areas, as generalized iodine supplementation is controversial. The aim of the present study was to establish thyroid stimulating hormone (TSH) and free thyroxine (FT4) reference values in the first trimester of gestation in the Valencian community (Spain) and relate them to iodine intake. A total of 261 healthy pregnant women participated in the study. The calculated reference values were 0.128&ndash

Adultendocrine systemendocrine system diseasesNutritional Statuschemistry.chemical_elementPhysiology030209 endocrinology & metabolismlcsh:TX341-641Thyroid Function TestsIodineArticleEating03 medical and health sciences0302 clinical medicineThyroid-stimulating hormonegestationPregnancymedicineHumans030212 general & internal medicineSodium Chloride Dietarythyroid hormonesiodine deficiencyPregnancyNutrition and Dieteticsbusiness.industryThyroidioduriaMaternal Nutritional Physiological Phenomenareference valuesmedicine.diseaseIodine deficiencyiodized saltHealthy VolunteersPregnancy Trimester FirstIodised saltCross-Sectional Studiesmedicine.anatomical_structurechemistrySpainReference valuesDietary SupplementsGestationFemalebusinesslcsh:Nutrition. Foods and food supplyhormones hormone substitutes and hormone antagonistsIodineFood ScienceNutrients
researchProduct

Fetal/Neonatal Thyrotoxicosis in a Newborn From a Hypothyroid Woman With Hashimoto Thyroiditis.

2016

Context: Fetal/neonatal thyrotoxicosis is a rare but potentially life-threatening condition. It is most commonly observed in poorly controlled Graves’ disease during pregnancy. Case Description: Here we describe the first reported case of thyrotoxicosis in a fetus/newborn from a woman with Hashimoto’s thyroiditis and levothyroxine-treated hypothyroidism. Transplacental passage of stimulating TSH-receptor antibodies, measured by a cell-based bioassay, was the underlying mechanism of fetal/neonatal thyrotoxicosis even though the mother had no history of hyperthyroidism. Conclusion: Diagnosis and management of fetal hyperthyroidism can be challenging. TSH receptor antibody testing should be co…

Adultendocrine systemmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismGraves' diseaseClinical Biochemistry030209 endocrinology & metabolismContext (language use)DiseaseHashimoto DiseaseBiochemistryThyroiditisInfant Newborn Diseases03 medical and health sciences0302 clinical medicineEndocrinologyHypothyroidismPregnancyInternal medicinemedicineHumansHashimoto DiseaseFetusPregnancybusiness.industryBiochemistry (medical)Infant NewbornTransplacentalmedicine.diseasePrognosisPregnancy ComplicationsFetal DiseasesEndocrinologyThyrotoxicosis030220 oncology & carcinogenesisFemalebusinesshormones hormone substitutes and hormone antagonistsImmunoglobulins Thyroid-StimulatingThe Journal of clinical endocrinology and metabolism
researchProduct

Interleukin-18 levels are associated with low-density lipoproteins size

2009

INTRODUCTION: Both low-density lipoproteins (LDL) size and serum interleukin (IL)-18 levels have been shown to be predictors of cardiovascular morbidity and mortality. However, it is still unknown whether IL-18 levels are independently associated with LDL size. METHODS: In this cross-sectional study including 53 premenopausal women (18-45 years), LDL size (by gradient gel electrophoresis), serum IL-18, high-sensitivity C-reactive protein (hs-CRP), serum lipids, insulin sensitivity (S(I), by frequently sampled intravenous glucose tolerance test) were measured. RESULTS: LDL size correlated with IL-18 (r = -0.38, P = 0.006), hs-CRP (r = -0.40, P = 0.003), S(I) (r = 0.36, P = 0.011), serum trig…

Adultmedicine.medical_specialty1303 BiochemistryAdolescentClinical Biochemistry10265 Clinic for Endocrinology and DiabetologyBlood lipidsInflammation610 Medicine & health1308 Clinical BiochemistryBiochemistryYoung AdultInternal medicinemedicineHumansRisk factorProspective cohort studyBeta (finance)TriglyceridesSubclinical infectionElectrophoresis Agar Gelbusiness.industryInterleukin-18InterleukinGeneral MedicineMiddle AgedLipoproteins LDLEndocrinologyC-Reactive ProteinCholesterolCross-Sectional StudiesCardiovascular Diseases10076 Center for Integrative Human Physiology570 Life sciences; biologylipids (amino acids peptides and proteins)Interleukin 18Femalemedicine.symptomInsulin Resistancebusinessaterosclerosi
researchProduct

Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis

2016

Summary: Our meta-analysis demonstrates that people with nephrolithiasis have decreased bone mineral density, an increased odds of osteoporosis, and potentially an elevated risk of fractures. Introduction: People with nephrolithiasis might be at risk of reduced bone mineral density (BMD) and fractures, but the data is equivocal. We conducted a meta-analysis to investigate if patients with nephrolithiasis have worse bone health outcomes (BMD), osteoporosis, and fractures versus healthy controls (HCs). Methods: Two investigators searched major databases for articles reporting BMD (expressed as g/cm2 or a T- or Z-score), osteoporosis or fractures in a sample of people with nephrolithiasis, and…

Adultmedicine.medical_specialtyBone mineral density Fractures Kidney stone Nephrolithiasis OsteoporosisEndocrinology Diabetes and MetabolismOsteoporosis030232 urology & nephrology030209 endocrinology & metabolismBone mineral density; Fractures; Kidney stone; Nephrolithiasis; OsteoporosisNephrolithiasisNO03 medical and health sciencesFractures Bone0302 clinical medicineBone DensityRisk FactorsInternal medicinemedicineBone mineral densityHumansKidney stoneFemoral neckBone mineralbusiness.industryHazard ratiomedicine.diseaseConfidence intervalRheumatologymedicine.anatomical_structureMeta-analysisOrthopedic surgeryOsteoporosisbusinessFractures
researchProduct

Inter-cycle and inter-observer variability of the antral follicle count in routine clinical practice

2017

Antral follicle count (AFC) is a reliable predictor of ovarian response to stimulation and its inter-cycle and inter-observer variability has been extensively studied on in vitro fertilization (IVF), mostly in highly selected populations within studies not originally designed for this purpose. In this retrospective cohort study, we assess the inter-cycle variation of AFC in a setting similar to that of the daily practice. We included only patients undergoing mild stimulation for intrauterine insemination (IUI). One hundred and forty-eight patients had two (62 patients, group A), three (49 patients, group B) or four (37 patients, group C) IUI cycles and AFC was measured on early follicular p…

Adultmedicine.medical_specialtyEndocrinology Diabetes and MetabolismConcordancemedicine.medical_treatmentCell Count030209 endocrinology & metabolismGroup BYoung Adult03 medical and health sciences0302 clinical medicineEndocrinologyOvarian FollicleOvulation InductionInternal medicinemedicineHumansRoutine clinical practiceOvarian ReserveOvarian reserveInsemination ArtificialMenstrual CycleRetrospective StudiesUltrasonographyObserver VariationGynecology030219 obstetrics & reproductive medicineIn vitro fertilisationbusiness.industryObstetrics and GynecologyRetrospective cohort studyAntral follicleFemalebusinessObserver variationGynecological Endocrinology
researchProduct

Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily.

2019

Objective To better characterize the metabolic alterations in various phenotypes of polycystic ovary syndrome (PCOS) in a large homogeneous (Sicilian) Mediterranean population with a low prevalence of obesity. Design Retrospective study. Patients A total of 1215 consecutively evaluated women with PCOS divided into four Rotterdam phenotypes (A, B, C and D) and in 108 matched ovulatory, nonhyperandrogenic women. Measurements BMI, fasting glucose, total cholesterol, HDL cholesterol, triglycerides, LDL cholesterol and an oral glucose tolerance test. Results The overall prevalence of obesity was 31%, metabolic syndrome 6.6%, diabetes 2.1%, altered glucose metabolism 13.1%, and abnormal lipid pro…

Adultmedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulation030209 endocrinology & metabolismCarbohydrate metabolism03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicinemedicineHumanseducationSicilyTriglyceridesRetrospective Studieseducation.field_of_studybusiness.industryCholesterolCholesterol HDLCholesterol LDLGlucose Tolerance Testmedicine.diseasePolycystic ovaryPhenotypeObesityEndocrinologychemistry030220 oncology & carcinogenesisFemaleMetabolic syndromebusinessPolycystic Ovary SyndromeClinical endocrinologyREFERENCES
researchProduct

Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis

2019

This study aimed to evaluate the prevalence (P)/hazard ratio (HR) of cardiovascular (CV) events among reproductive age and menopausal age women with polycystic ovary syndrome (PCOS) in comparison with healthy controls. PubMed, Scopus, ScienceDirect, Web of science, and Google scholar were searched for retrieving observational studies published up to April 2018 investigating CV events in patients with PCOS. The primary outcomes were a composite outcome of CV events [including coronary arterial disease (CAD), cardiovascular disease (CVD), myocardial infarction (MI), angina, heart failure, and ischemic heart disease] and mortality due to CV events; secondary outcomes were specific CVD events, …

Adultmedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationMyocardial InfarctionMyocardial Ischemia030209 endocrinology & metabolismCoronary Artery DiseaseAngina PectorisAngina03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicinePrevalencemedicineHumansMyocardial infarctionRisk factoreducationAgedProportional Hazards ModelsHeart Failureeducation.field_of_study030219 obstetrics & reproductive medicinebusiness.industryPolycystic ovary syndrome (PCOS)Hazard ratioObstetrics and GynecologyMiddle Agedmedicine.diseasePolycystic ovaryStrokeCerebrovascular DisordersCardiovascular DiseasesCase-Control StudiesFemalebusinessPolycystic Ovary SyndromeCohort studyGynecological Endocrinology
researchProduct

Neuromuscular performance and body mass as indices of bone loading in premenopausal and postmenopausal women.

2009

The strong association between body mass and skeletal robusticity has been attributed to increasing skeletal loading with increasing mass. However, it is unclear whether body mass is merely a coarse substitute for bone loading rather than a true independent predictor of bone strength. As indices of neuromuscular performance, impulse and peak power were determined from vertical ground reaction force during a maximal counter movement jump test in 221 premenopausal and 82 postmenopausal women. Bone compressive (BSI(d) g(2)/cm(4)) and bending (SSImax(mid) mm(3)) strength indices were measured with peripheral quantitative computed tomography (pQCT) at the distal ((d)) and midshaft ((mid)) sites …

Adultmedicine.medical_specialtyHistologyCompressive StrengthPhysiologyEndocrinology Diabetes and MetabolismMovementPhysical Exertion030209 endocrinology & metabolismIndependent predictorWeight-Bearing03 medical and health sciences0302 clinical medicineBone strengthBone loadingWeight lossOsteoarthritisMedicineHumansTibiaMuscle StrengthQuantitative computed tomography030304 developmental biologyOrthodontics0303 health sciencesHip fracturePostmenopausal womenmedicine.diagnostic_testTibiabusiness.industryBody WeightAge FactorsMiddle Agedmedicine.diseaseSurgeryPostmenopauseRadiographyPremenopauseBody CompositionRegression AnalysisFemaleStress Mechanicalmedicine.symptombusinessMuscle ContractionBone
researchProduct

Change in active transportation and weight gain in pregnancy

2016

Background: Pregnancy is characterised by large weight gain over a short period, and often a notable change in mode of transportation. This makes pregnancy suitable for examining the plausible, but in the scientific literature still unclear, association between active transportation and weight gain. We hypothesize that women continuing an active mode of transportation to work or school from pre- to early pregnancy will have a lower gestational weight gain (GWG) than those who change to a less active mode of transportation. Methods: We analysed prospective data from the Norwegian Fit for Delivery (NFFD) trial. Between September 2009 and February 2013 606 women were consecutively enrolled in …

Adultmedicine.medical_specialtyMedicine (miscellaneous)Poison controlPublic transportationTransportation030209 endocrinology & metabolismPhysical Therapy Sports Therapy and RehabilitationWalkingClinical nutritionWeight GainBody Mass IndexBMIYoung Adult03 medical and health sciences0302 clinical medicinePregnancymedicineActive transportationHumansObesityProspective Studies030212 general & internal medicineProspective cohort studyPregnancyNutrition and DieteticsNorwayObstetricsbusiness.industryResearchBody Weightmedicine.diseaseObesityBicyclingPregnancy ComplicationsBikingPhysical therapyGestationFemalemedicine.symptombusinessBody mass indexWeight gainInternational Journal of Behavioral Nutrition and Physical Activity
researchProduct

Maternal-fetal Complications in Pregnancy: A Retrospective Comparison Between Type 1 and Type 2 Diabetes Mellitus

2021

Abstract Background The aim of the study was a retrospective comparison of the differences in maternal-foetal outcomes between women with type 1 and type 2 diabetes mellitus (T1DM and T2DM). Methods A cohort of 135 patients with pregestational diabetes, 73 with T1DM (mean age 29 ± 5 years) and 62 with T2DM (mean age 33 ± 6 years), in intensive insulin treatment throughout pregnancy were evaluated. Clinical and metabolic parameters and the prevalence of maternal and foetal complications were assessed. Results Women with T1DM showed lower pregestational BMI (p < 0.001), pregestational weight (p < 0.001), weight at delivery (p < 0.001), ∆_total_insulin requirement (IR) at the first, s…

Adultmedicine.medical_specialtyMultivariate analysisendocrine system diseasesmedicine.medical_treatmentReproductive medicine030209 endocrinology & metabolismAbortionMacrosomialcsh:Gynecology and obstetricsBody Mass IndexFetal Macrosomia03 medical and health sciencesYoung Adult0302 clinical medicinePregnancyRisk FactorsInsulin requirementmedicinePrevalenceHumansInsulinlcsh:RG1-991Retrospective StudiesGlycated HemoglobinPregnancy030219 obstetrics & reproductive medicineObstetricsbusiness.industryInsulinAbortionObstetrics and GynecologyType 2 Diabetes Mellitusnutritional and metabolic diseasesmedicine.diseaseGestational Weight GainAbortion SpontaneousDiabetes Mellitus Type 1Diabetes Mellitus Type 2Large for gestational ageCohortFemalePregnancy Trimestersmedicine.symptomInsulin ResistancebusinessWeight gainResearch Article
researchProduct